Detail
| LncRNA Name | SNHG5 |
| Synonyms | SNHG5, C6orf160, LINC00044, U50HG, bA33E24.2, MGC16362, bA33E24.2, U50HG, NCRNA00044 |
| Region | GRCh38_6:85660950-85678736 Sequence |
| Ensembl | ENSG00000203875 |
| RefSeq | NR_003038 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | acute myeloid leukemia |
| ICD-0-3 | M9861/3 |
| Methods | qPCR |
| Sample | blood |
| Expression Pattern | up-regulated |
| Function Description | SNHG5 upregulation more frequently occurred in AML patients with advanced FAB classification (p<0.005) and unfavorable cytogenetics (p=0.001). overall patient survival for those with high plasma SNHG5 expression was significantly shorter than those patients with low SNHG5 expression. |
| Pubmed ID | 29917184 |
| Year | 2018 |
| Title | Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia. |
| External Links |
| Links for SNHG5 | GenBank HGNC lncrnadb Noncode |
| Links for acute myeloid leukemia | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.